Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038/35021093.
Article
CAS
PubMed
Google Scholar
Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98: 10869-10874. 10.1073/pnas.191367098.
Article
PubMed
PubMed Central
Google Scholar
Polyak K: Heterogeneity in breast cancer. J Clin Invest. 2011, 121: 3786-3788. 10.1172/JCI60534.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO: Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008, 14: 1368-1376. 10.1158/1078-0432.CCR-07-1658.
Article
CAS
PubMed
Google Scholar
Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO: Triple-negative breast cancer: distinguishing between basal and nonbasal sub-types. Clin Cancer Res. 2009, 15: 2302-2310. 10.1158/1078-0432.CCR-08-2132.
Article
CAS
PubMed
Google Scholar
Lechertier T, Hodivala-Dilke K: Focal adhesion kinase and tumour angiogenesis. J Pathol. 2012, 226: 404-412. 10.1002/path.3018.
Article
CAS
PubMed
Google Scholar
Luo M, Guan JL: Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett. 2010, 289: 127-139. 10.1016/j.canlet.2009.07.005.
Article
CAS
PubMed
Google Scholar
Ji HF, Pang D, Fu SB, Jin Y, Yao L, Qi JP, Bai J: Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer. J Cancer Res Clin Oncol. 2013, 139: 429-435. 10.1007/s00432-012-1342-8.
Article
CAS
PubMed
Google Scholar
Lightfoot HM, Lark A, Livasy CA, Moore DT, Cowan D, Dressler L, Craven RJ, Cance WG: Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumourigenesis. Breast Cancer Res Treat. 2004, 88: 109-116. 10.1007/s10549-004-1022-8.
Article
CAS
PubMed
Google Scholar
Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG: Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol. 2003, 34: 240-245. 10.1053/hupa.2003.40.
Article
CAS
PubMed
Google Scholar
Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG: Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res. 1995, 55: 2752-2755.
CAS
PubMed
Google Scholar
Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA: High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res. 2005, 7: R194-203. 10.1186/bcr977.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH: Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol. 2006, 37: 9-15. 10.1016/j.humpath.2005.09.024.
Article
CAS
PubMed
Google Scholar
Haskell H, Natarajan M, Hecker TP, Ding Q, Stewart J, Grammer R, Gladson CL: Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumours in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res. 2003, 9: 2157-2165.
CAS
PubMed
Google Scholar
McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, Hodivala-Dilke K, Metzger D, Chambon P, Grant SG, Frame MC: Specific deletion of focal adhesion kinase suppresses tumour formation and blocks malignant progression. Genes Dev. 2004, 18: 2998-3003. 10.1101/gad.316304.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD: VEGF-induced vascular permeability is mediated by FAK. Dev Cell. 2012, 22: 146-157. 10.1016/j.devcel.2011.11.002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M, Hodivala-Dilke KM: Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med. 2010, 2: 516-528. 10.1002/emmm.201000106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kostourou V, Lechertier T, Reynolds LE, Lees DM, Baker M, Jones DT, Tavora B, Ramjaun AR, Birdsey GM, Robinson SD, Parsons M, Randi AM, Hart IR, Hodivala-Dilke K: FAK-heterozygous mice display enhanced tumour angiogenesis. Nat Commun. 2020, 2013: 4-
Google Scholar
Schultze A, Fiedler W: Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase. Anticancer Agents Med Chem. 2011, 11: 593-599. 10.2174/187152011796817727.
Article
CAS
PubMed
Google Scholar
Leong AS, Zhuang Z: The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology. 2011, 78: 99-114. 10.1159/000292644.
Article
CAS
PubMed
PubMed Central
Google Scholar
McShane LM1, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM: Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics: REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005, 93 (4): 387-391. 10.1038/sj.bjc.6602678.
Article
CAS
PubMed
PubMed Central
Google Scholar
Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, Wang R: Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol. 2006, 172: 151-162. 10.1083/jcb.200506184.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 1995, 377: 539-544. 10.1038/377539a0.
Article
CAS
PubMed
Google Scholar
Shen TL, Park AY, Alcaraz A, Peng X, Jang I, Koni P, Flavell RA, Gu H, Guan JL: Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol. 2005, 169: 941-952. 10.1083/jcb.200411155.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lark AL, Livasy CA, Dressler L, Moore DT, Millikan RC, Geradts J, Iacocca M, Cowan D, Little D, Craven RJ, Cance W: High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol. 2005, 18: 1289-1294. 10.1038/modpathol.3800424.
Article
CAS
PubMed
Google Scholar
Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, Moore D, Millikan RC, Cance WG: FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer. 2009, 125: 1735-1738. 10.1002/ijc.24486.
Article
CAS
PubMed
PubMed Central
Google Scholar
Theocharis SE, Klijanienko JT, Padoy E, Athanassiou S, Sastre-Garau XX: Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumour proliferative capacity. Med Sci Monit. 2009, 15: BR221-BR226.
CAS
PubMed
Google Scholar
Yom CK, Noh DY, Kim WH, Kim HS: Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer. Breast Cancer Res Treat. 2011, 128: 647-655. 10.1007/s10549-010-1150-2.
Article
CAS
PubMed
Google Scholar
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19: 403-410. 10.1111/j.1365-2559.1991.tb00229.x.
Article
CAS
PubMed
Google Scholar
De Laurentiis M, Cianniello D, Caputo R, Stanzione B, Arpino G, Cinieri S, Lorusso V, De Placido S: Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treat Rev. 2010, 36: S80-S86.
Article
CAS
PubMed
Google Scholar
Rydén L, Jirström K, Haglund M, Stål O, Fernö M: Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up. Breast Cancer Res Treat. 2010, 120: 491-498. 10.1007/s10549-010-0758-6.
Article
PubMed
Google Scholar
Perou CM: Molecular stratification of triple-negative breast cancers. Oncologist. 2011, 16: 61-70.
Article
PubMed
Google Scholar